Haematological Profile and ACE2 Levels of COVID-19 Patients in a Metropolis in Ghana
dc.contributor.author | Ackah, Ezekiel B. | |
dc.contributor.author | Owusu, Michael | |
dc.contributor.author | Sackey, Benedict | |
dc.contributor.author | Boamah, Justice K. | |
dc.contributor.author | Kamasah, Japhet S. | |
dc.contributor.author | Aduboffour, Albert A. | |
dc.contributor.author | Akortia, Debora | |
dc.contributor.author | Nkrumah, Gifty | |
dc.contributor.author | Amaniampong, Andrews | |
dc.contributor.author | Klevor, Nicholas | |
dc.contributor.author | Agyemang, Lawrence D. | |
dc.contributor.author | Ayisi-Boateng, Nana K. | |
dc.contributor.author | Sylverken, Augustina | |
dc.contributor.author | Phillips, Richard Odame | |
dc.contributor.author | Owusu-Dabo, Ellis | |
dc.contributor.orcid | 0000-0001-7491-5420 | |
dc.contributor.orcid | 0000-0001-5066-150X | |
dc.contributor.orcid | 0000-0003-1016-7720 | |
dc.contributor.orcid | 0000-0003-0369-555X | |
dc.contributor.orcid | 0000-0002-0961-4434 | |
dc.contributor.orcid | 0000-0002-7691-914X | |
dc.contributor.orcid | 0000-0001-8992-0222 | |
dc.contributor.orcid | 0000-0003-4232-4292 | |
dc.date.accessioned | 2024-02-16T13:06:11Z | |
dc.date.available | 2024-02-16T13:06:11Z | |
dc.date.issued | 2024 | |
dc.description | This is an article published by Ackah, E.B.; Owusu, M.; Sackey, B.; Boamah, J.K.; Kamasah, J.S.; Aduboffour, A.A.; Akortia, D.; Nkrumah, G.; Amaniampong, A.; Klevor, N.; et al. Haematological Profile and ACE2 Levels of COVID-19 Patients in a Metropolis in Ghana. COVID 2024, 4, 117–129. https://doi.org/10.3390/covid4020011 | |
dc.description.abstract | Background: Several studies have linked coronavirus disease 2019 (COVID-19) risk to age and ABO blood groups. Variations in plasma angiotensin-converting enzyme 2 (ACE2) levels and blood counts have been reported, suggesting an association between disease severity and low lymphocyte levels. Aim: this study aimed to understand how these factors relate to COVID-19 in Ghanaian patients, considering geographical and demographic differences. Methods: Participants were recruited from six hospitals in Kumasi, Ghana, between June 2020 and July 2021. Nasopharyn geal swabs were taken to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and blood samples were collected for complete blood count testing, ABO/Rhesus typing, and assessment of plasma ACE2 levels. Demographic and COVID-19 severity data were gathered, and IBM SPSS version 25.0 was used for analysis. Results: Overall, 515 patients were enrolled, out of which 55.9% (n = 288/515) were males and 50.3% (n = 259/515) tested positive for SARS-CoV-2. The median age was 37 years (IQR = 26–53). Age was significantly associated with SARS-CoV-2 infection (p = 0.002). The severe COVID-19 group was the oldest (70 years, IQR = 35–80) and presented with anaemia (haemoglobin, g/dL: 9.55, IQR = 7.85–11.93), leukocytosis (WBC × 103/µL: 15.87, IQR = 6.68–19.80), neutrophilia (NEUT × 106/µL: 14.69, IQR = 5.70–18.96) and lymphocytopenia (LYMPH × 106/µL: 0.47, IQR = 0.22–0.66). No association was found between SARS-CoV-2 positivity and ABO (p = 0.711) or Rh (p = 0.805) blood groups; no association was also found between plasma ACE2 levels and SARS-CoV-2 status (p = 0.079). However, among COVID-19 participants, plasma ACE2 levels were significantly reduced in the moderate illness group (40.68 ng/mL, IQR = 34.09–48.10) compared with the asymptomatic group (50.61 ng/mL, IQR = 43.90–58.61, p = 0.015). Conclusions: While there may be no real association between the ABO blood group, as well as plasma ACE2 levels, and SARS-CoV-2 infection in Ghanaian patients, older individuals are at a higher risk of severe disease. Anaemia, and leukocytosis with lymphocytopenia may be indicators of poor disease progression. | |
dc.description.sponsorship | KNUST | |
dc.identifier.citation | Ackah, E.B.; Owusu, M.; Sackey, B.; Boamah, J.K.; Kamasah, J.S.; Aduboffour, A.A.; Akortia, D.; Nkrumah, G.; Amaniampong, A.; Klevor, N.; et al. Haematological Profile and ACE2 Levels of COVID-19 Patients in a Metropolis in Ghana. COVID 2024, 4, 117–129. https:// doi.org/10.3390/covid4020011 | |
dc.identifier.uri | https:// doi.org/10.3390/covid4020011 | |
dc.identifier.uri | https://ir.knust.edu.gh/handle/123456789/15491 | |
dc.language.iso | en | |
dc.publisher | COVID | |
dc.title | Haematological Profile and ACE2 Levels of COVID-19 Patients in a Metropolis in Ghana | |
dc.type | Article |